The mortality rates for stomach malignant neoplasms among males in Japan are forecasted to decline over the coming years. In 2023, this rate stood at a higher level, but by 2024, it is expected to drop to 24.4 deaths per hundred thousand men. The trend continues with a yearly decline of approximately 5.7% from 2024 to 2028, reaching 18.9 by 2028. This indicates a significant decrease with a compound annual growth rate (CAGR) of around -6% over the five-year period.
Future trends to watch for include advancements in early detection and treatment, which may further influence mortality rates positively. Additionally, public health initiatives and lifestyle changes could also impact these trends significantly.
